mk2 Biotechnologies
Marco Giuman is an experienced professional in the biotechnology sector, currently serving as Managing Director at mk2 Biotechnologies since September 2018. In this role, Marco oversees research and development, lab management, and intellectual property management. Prior to this position, Marco worked at Technische Universität München from October 2014 to August 2018 as a Wissenschaftlicher Mitarbeiter, conducting research on the recombinant synthesis and purification of fusion proteins and serving as a PhD student focused on Al(III)-based group transfer polymerization of polar monomers. Marco holds a Master of Science degree in Chemistry obtained from the Technical University of Munich in 2014 and a Bachelor of Science degree in Chemistry earned in 2011 from the same institution.
This person is not in any teams
mk2 Biotechnologies
mk2 Biotechnologies develops, produces and investigates peptides & proteins using a revolutionary synthesis technology. Our innovative process allows the scalable and thus cost-efficient production of high-purity peptides & proteins for a broad range of applications.